Tenofovir alafenamide/tenofovir disoproxil fumarateAcute tubular necrosis: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-021-00845-2
中图分类号
学科分类号
摘要
引用
收藏
页码:388 / 388
相关论文
共 50 条
  • [41] Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide
    Podany, Anthony T.
    Bares, Sara H.
    Havens, Joshua
    Dyavar, Shetty Ravi
    O'Neill, Jennifer
    Lee, Sarah
    Fletcher, Courtney V.
    Swindells, Susan
    Scarsi, Kimberly K.
    [J]. AIDS, 2018, 32 (06) : 761 - 765
  • [47] Atherosclerotic CVD risk profile of tenofovir alafenamide versus tenofovir disoproxil fumarate
    Huhn, G.
    Shamblaw, D.
    Baril, J. G.
    Baker, D.
    Ward, D.
    Guo, S.
    Haubrich, R.
    Nguyen-Cleary, T.
    McCallister, S.
    Das, M.
    [J]. ANTIVIRAL THERAPY, 2016, 21 : A45 - A45
  • [48] Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
    Hill, A.
    Hughes, S.
    Pozniak, A.
    [J]. HIV MEDICINE, 2018, 19 : S30 - S30
  • [49] Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2
    Cusato, Jessica
    Calcagno, Andrea
    De Nicolo, Amedeo
    Mogyorosi, Karoly
    D'Avolio, Antonio
    Di Perri, Giovanni
    Bonora, Stefano
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 94 (02) : 202 - 204
  • [50] Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
    Hill, Andrew
    Hughes, Sophie L.
    Gotham, Dzintars
    Pozniak, Anton L.
    [J]. JOURNAL OF VIRUS ERADICATION, 2018, 4 (02) : 72 - 79